- D81.82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D81.82 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D81.82 – other international versions of ICD-10 D81.82 may differ.
ICD-10-CM D81.82 is grouped within Diagnostic Related Group(s):
- 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
- 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
- 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc
Applicable To
- p110d-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] disease
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D81.82:
- p110d-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency [PASLI] > Disease, diseased
- activated phosphoinositide 3-kinase delta syndrome [APDS] > Syndrome